Chinese Journal of Cancer Research最新文献

筛选
英文 中文
Preface to Special Issue: Cancer epidemiology, risk factors and screening. 特刊序言:癌症流行病学、风险因素和筛查。
IF 7 2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.01
Binghe Xu, Hangcheng Xu
{"title":"Preface to Special Issue: Cancer epidemiology, risk factors and screening.","authors":"Binghe Xu, Hangcheng Xu","doi":"10.21147/j.issn.1000-9604.2023.06.01","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.01","url":null,"abstract":"","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"563-564"},"PeriodicalIF":7.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Double-tract reconstruction is superior to esophagogastrostomy in controlling reflux esophagitis and enhancing quality of life after proximal gastrectomy: Results from a prospective randomized controlled clinical trial in China. 在控制反流性食管炎和提高近端胃切除术后生活质量方面,双管重建术优于食管胃造瘘术:中国一项前瞻性随机对照临床试验的结果。
2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.09
Yinan Zhang, Hongtao Zhang, Yan Yan, Ke Ji, Ziyu Jia, Heli Yang, Biao Fan, Anqiang Wang, Xiaojiang Wu, Ji Zhang, Jiafu Ji, Xin Ji, Zhaode Bu
{"title":"Double-tract reconstruction is superior to esophagogastrostomy in controlling reflux esophagitis and enhancing quality of life after proximal gastrectomy: Results from a prospective randomized controlled clinical trial in China.","authors":"Yinan Zhang, Hongtao Zhang, Yan Yan, Ke Ji, Ziyu Jia, Heli Yang, Biao Fan, Anqiang Wang, Xiaojiang Wu, Ji Zhang, Jiafu Ji, Xin Ji, Zhaode Bu","doi":"10.21147/j.issn.1000-9604.2023.06.09","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.09","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to prospectively compare double-tract reconstruction (DTR) and esophagogastrostomy (EG) after proximal gastrectomy (PG) regarding the incidence of reflux esophagitis, quality of life (QOL), nutritional status and surgical safety.</p><p><strong>Methods: </strong>This study was a randomized controlled trial. Patients eligible for PG were enrolled and randomly assigned to the EG group and DTR group. The characteristics of patients, parameters for surgical safety, incidence of reflux esophagitis, nutrition status and QOL were collected and compared between the two groups. Univariate analysis and multivariate analysis were performed to determine the significant factors affecting the incidence of reflux esophagitis after PG.</p><p><strong>Results: </strong>Thirty-seven patients of the EG group and 36 patients of the DTR group were enrolled. The incidence of reflux esophagitis was significantly lower in the DTR group than in the EG group (8.3% <i>vs.</i> 32.4%, P=0.019). The DTR group demonstrated a more favorable QOL than the EG group after PG. The nutritional status was balanced within the EG group and the DTR group. The operation time was longer in the DTR group than in the EG group (191 min <i>vs.</i> 221 min, P=0.001), while surgical safety was similar in the two groups.</p><p><strong>Conclusions: </strong>Our research demonstrated that DTR is superior to EG after PG in terms of the incidence of reflux esophagitis and provides a more satisfactory QOL without increasing surgical complications or sacrificing nutritional status.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"645-659"},"PeriodicalIF":0.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast cancer: Epidemiology, risk factors and screening. 乳腺癌:流行病学、风险因素和筛查。
2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.02
Hangcheng Xu, Binghe Xu
{"title":"Breast cancer: Epidemiology, risk factors and screening.","authors":"Hangcheng Xu, Binghe Xu","doi":"10.21147/j.issn.1000-9604.2023.06.02","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.02","url":null,"abstract":"<p><p>Breast cancer is a global health concern with a significant impact on the well-being of women. Worldwide, the past several decades have witnessed changes in the incidence and mortality of breast cancer. Additionally, epidemiological data reveal distinct geographic and demographic disparities globally. A range of modifiable and non-modifiable risk factors are established as being associated with an increased risk of developing breast cancer. This review discusses genetic, hormonal, behavioral, environmental, and breast-related risk factors. Screening plays a critical role in the effective management of breast cancer. Various screening modalities, including mammography, ultrasound, magnetic resonance imaging (MRI), and physical examination, have different applications, and a combination of these modalities is applied in practice. Current screening recommendations are based on factors including age and risk, with a significant emphasis on minimizing potential harms to achieve an optimal benefits-to-harms ratio. This review provides a comprehensive insight into the epidemiology, risk factors, and screening of breast cancer. Understanding these elements is crucial for improving breast cancer management and reducing its burden on affected individuals and healthcare systems.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"565-583"},"PeriodicalIF":0.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and early screening strategies for colorectal cancer in China. 中国结直肠癌的流行病学和早期筛查策略。
IF 7 2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.05
Yong Yang, Zhaoya Gao, An Huang, Jingyi Shi, Zhuang Sun, Haopeng Hong, Jin Gu
{"title":"Epidemiology and early screening strategies for colorectal cancer in China.","authors":"Yong Yang, Zhaoya Gao, An Huang, Jingyi Shi, Zhuang Sun, Haopeng Hong, Jin Gu","doi":"10.21147/j.issn.1000-9604.2023.06.05","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.05","url":null,"abstract":"<p><p>China ranks the first worldwide in the number of new colorectal cancer (CRC) cases and CRC-related deaths. The increasing incidence of early-onset CRC in recent years highlights the challenges related to CRC screening and prevention. High-quality colonoscopy is the universally used gold standard for CRC screening. Risk assessment combined with a two-step screening strategy based on colonoscopy and non-invasive examinations was proven to be highly effective. However, systematic use of well-established risk factors associated with CRC, beyond age, could better identify those who might harbor advanced colorectal neoplasia, improve the diagnostic yield of current screening modalities, and optimize the selection of individuals who might benefit most from preventive strategies. \"Personalization\" and \"Standardization\" are the future development directions of CRC screening, from the initiation of screening in those at high risk for CRC to follow-up after treatment, which are the key to ensure the screening efficiency.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"606-617"},"PeriodicalIF":7.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric cancer surgery in South Korea: Past, present, and future. 韩国的胃癌手术:过去、现在和未来。
2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.07
Sung Gon Kim, Sang Eok Lee, Bang Wool Eom, Hong Man Yoon, Young-Woo Kim, Keun Won Ryu
{"title":"Gastric cancer surgery in South Korea: Past, present, and future.","authors":"Sung Gon Kim, Sang Eok Lee, Bang Wool Eom, Hong Man Yoon, Young-Woo Kim, Keun Won Ryu","doi":"10.21147/j.issn.1000-9604.2023.06.07","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.07","url":null,"abstract":"<p><p>Gastric cancer remains a significant global health concern and its surgical management approaches have undergone significant changes in South Korea and worldwide. Subtotal or total gastrectomy with D2 lymph node dissection is well established as a standard surgical procedure for gastric cancer. With the active implementation of cancer screening in South Korea, the proportion of early gastric cancer cases has significantly increased over the past few decades, leading to a steady increase in the survival rate among patients. Furthermore, recent advances in surgical instruments and techniques have made minimally invasive surgery increasingly prevalent, not only for early but also for advanced gastric cancer. We aim to provide a comprehensive overview of the evolution and current status of gastric cancer surgery in South Korea.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"627-635"},"PeriodicalIF":0.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis. 揭示 CXCL12 在膀胱癌中的临床意义和肿瘤免疫格局:多重全息分析的启示
2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.12
Zhouting Tuo, Dechao Feng, Zhiwei Jiang, Liangkuan Bi, Chao Yang, Qi Wang
{"title":"Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis.","authors":"Zhouting Tuo, Dechao Feng, Zhiwei Jiang, Liangkuan Bi, Chao Yang, Qi Wang","doi":"10.21147/j.issn.1000-9604.2023.06.12","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.12","url":null,"abstract":"<p><strong>Objective: </strong>The interplay between chemokine C-X-C motif ligand 12 (CXCL12) and its specific receptors is known to trigger various signaling pathways, contributing to tumor proliferation and metastasis. Consequently, targeting this signaling axis has emerged as a potential strategy in cancer therapy. However, the precise role of CXCL12 in clinical therapy, especially in immunotherapy for bladder cancer (BCa), remains poorly elucidated.</p><p><strong>Methods: </strong>We gathered multiple omics data from public databases to unveil the clinical relevance and tumor immune landscape associated with CXCL12 in BCa patients. Univariate and multivariate Cox regression analyses were employed to assess the independent prognostic significance of CXCL12 expression and formulate a nomogram. The expression of CXCL12 in BCa cell lines and clinical tissue samples was validated using enzyme-linked immunosorbent assays (ELISA) and immunohistochemistry (IHC).</p><p><strong>Results: </strong>While transcriptional expression of CXCL12 exhibited a decrease in nearly all tumor tissues, CXCL12 methylation expression was notably increased in BCa tissues. Single-cell RNA analysis highlighted tissue stem cells and endothelial cells as the primary sources expressing CXCL12. Abnormal CXCL12 expression, based on transcriptional and methylation levels, correlated with various clinical characteristics in BCa patients. Functional analysis indicated enrichment of CXCL12 and its co-expression genes in immune regulation and cell adhesion. The immune landscape analysis unveiled a significant association between CXCL12 expression and M2 macrophages (CD163<sup>+</sup> cells) in BCa tissues. Notably, CXCL12 expression emerged as a potential predictor of immunotherapy response and chemotherapy drug sensitivity in BCa patients.</p><p><strong>Conclusions: </strong>Taken together, these findings suggest aberrant production of CXCL12 in BCa tissues, potentially influencing the treatment responses of affected individuals.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"686-701"},"PeriodicalIF":0.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774138/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention. 基于人群的幽门螺杆菌根除和内窥镜胃癌筛查的卫生经济评估。
2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.04
Zhiqiang Hu, Zongchao Liu, Wenqing Li, Weicheng You, Kaifeng Pan
{"title":"Health economic evaluation on population-based <i>Helicobacter pylori</i> eradication and endoscopic screening for gastric cancer prevention.","authors":"Zhiqiang Hu, Zongchao Liu, Wenqing Li, Weicheng You, Kaifeng Pan","doi":"10.21147/j.issn.1000-9604.2023.06.04","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.04","url":null,"abstract":"<p><p>Gastric cancer is a global public health burden, nearly one million new cases are diagnosed per year worldwide, of which 44% of cases occur in China. The prognosis of gastric cancer varies remarkably by the stage of cancer, and most of the patients in China are diagnosed at advanced stages, resulting in poor prognoses. Effective strategies to reduce the burden of gastric cancer include primary prevention through testing and treatment of <i>Helicobacter pylori</i> (<i>H. pylori</i>) and secondary prevention by screening and early detection. Although many countries have issued management guidelines and consensus reports concerning these strategies, the limited availability of healthcare resources often precludes their widespread implementation. Therefore, assessing the costs, benefits, and harms of population-based intervention measures through health economic evaluation is necessary for informed health policy decisions. Accordingly, we synthesize management approaches from different countries on <i>H. pylori</i> eradication and endoscopic screening, and also summarize recent advancements in health economic evaluations on population-based preventive strategies. The goal of the review is to provide empirical evidence supporting optimal resource allocation, maximizing benefits for the population, and ultimately reducing the burden of gastric cancer.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"595-605"},"PeriodicalIF":0.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benchmark for establishment of organoids from gastrointestinal epithelium and cancer based on available consumables and reagents. 根据现有消耗品和试剂,建立胃肠道上皮细胞和癌症器官组织的基准。
2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.08
Ruixin Yang, Zhen Xiang, Ranlin Yan, Wingyan Kwan, Lu Zang, Zhenggang Zhu, Yao Qi, Yanping Xu, Xiaoyan Zhang, Hengjun Gao, Yingyan Yu
{"title":"Benchmark for establishment of organoids from gastrointestinal epithelium and cancer based on available consumables and reagents.","authors":"Ruixin Yang, Zhen Xiang, Ranlin Yan, Wingyan Kwan, Lu Zang, Zhenggang Zhu, Yao Qi, Yanping Xu, Xiaoyan Zhang, Hengjun Gao, Yingyan Yu","doi":"10.21147/j.issn.1000-9604.2023.06.08","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.08","url":null,"abstract":"<p><p>Gastrointestinal cancers are a public health problem that threatens the lives of human being. A good experimental model is a powerful tool to promote the uncovering pathogenesis and establish novel treatment methods. High-quality biomedical research requires experimental models to recapitulate the physiological and pathological states of their parental tissues as much as possible. Organoids are such experimental models. Organoids refer to small organ-like cellular clusters formed by the expansion and passaging of living tissues in 3D culture medium <i>in vitro</i>. Organoids are highly similar to the original tissues in terms of cellular composition, cell functions, and genomic profiling. Organoids have many advantages, such as short preparation cycles, long-term storage based on cryopreservation, and reusability. In recent years, researchers carried out the establishment of organoids from gastrointestinal mucosa and cancer tissues, and accumulated valuable experiences. In order to promote effective usage and further development of organoid-related technologies in the research of gastrointestinal diseases, this study proposes a benchmark based on utilization of available experimental consumables and reagents, which are involved in the key steps such as collection and pretreatment of biospecimen, organoid construction, organoid cryopreservation and recovery, growth status evaluation, and organoid quality control. We believe that the standard for the construction and preservation of organoids derived from human gastrointestinal epithelium and cancer tissues can provide an important reference for the majority of scientific researchers.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"636-644"},"PeriodicalIF":0.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring ideal operative time for best outcomes in gastric cancer surgery: A multi-institutional study based on KLASS-07 database. 探索胃癌手术最佳疗效的理想手术时间:基于 KLASS-07 数据库的多机构研究。
2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-12-30 DOI: 10.21147/j.issn.1000-9604.2023.06.10
Shin-Hoo Park, Ye-Rim Shin, Hoon Hur, Chang Min Lee, Jae Seok Min, Seung Wan Ryu, Hyun Dong Chae, Oh Jeong, Chang-In Choi, Kyo-Young Song, Ho Goon Kim, Ye Seob Jee, Kwang Hee Kim, Jeong Goo Kim, Kyung Sook Yang, Hua Huang, Sungsoo Park
{"title":"Exploring ideal operative time for best outcomes in gastric cancer surgery: A multi-institutional study based on KLASS-07 database.","authors":"Shin-Hoo Park, Ye-Rim Shin, Hoon Hur, Chang Min Lee, Jae Seok Min, Seung Wan Ryu, Hyun Dong Chae, Oh Jeong, Chang-In Choi, Kyo-Young Song, Ho Goon Kim, Ye Seob Jee, Kwang Hee Kim, Jeong Goo Kim, Kyung Sook Yang, Hua Huang, Sungsoo Park","doi":"10.21147/j.issn.1000-9604.2023.06.10","DOIUrl":"10.21147/j.issn.1000-9604.2023.06.10","url":null,"abstract":"<p><strong>Objective: </strong>While a rushed operation can omit essential procedures, prolonged operative time results in higher morbidity. Nevertheless, the optimal operative time range remains uncertain. This study aimed to estimate the ideal operative time range and evaluate its applicability in laparoscopic cancer surgery.</p><p><strong>Methods: </strong>A prospectively collected multicenter database of 397 patients who underwent laparoscopic distal gastrectomy were retrospectively reviewed. The ideal operative time range was statistically calculated by separately analyzing the operative time of uneventful surgeries. Finally, intraoperative and postoperative outcomes were compared among the shorter, ideal, and longer operative time groups.</p><p><strong>Results: </strong>The statistically calculated ideal operative time was 135.4-165.4 min. The longer operative time (LOT) group had a lower rate of uneventful, perfect surgery than the ideal or shorter operative time (IOT/SOT) group (2.8% <i>vs.</i> 8.8% and 2.2% <i>vs.</i> 13.4%, all P<0.05). Longer operative time increased bleeding, postoperative morbidities, and delayed diet and discharge (all P<0.05). Particularly, an uneventful, perfect surgery could not be achieved when the operative time exceeded 240 min. Regardless of ideal time range, SOT group achieved the highest percentage of uneventful surgery (13.4%), which was possible by surgeon's ability to retrieve a higher number of lymph nodes and perform ≥150 gastrectomies annually.</p><p><strong>Conclusions: </strong>Operative time longer than the ideal time range (especially ≥240 min) should be avoided. If the essential operative procedure were faithfully conducted without compromising oncological safety, an operative time shorter than the ideal range leaded to a better prognosis. Efforts to minimize operative time should be attempted with sufficient surgical experience.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 6","pages":"660-674"},"PeriodicalIF":0.0,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version). 国家卫健委《2023年中国结直肠癌诊疗指南》(英文版)意见
2区 医学
Chinese Journal of Cancer Research Pub Date : 2023-10-30 DOI: 10.21147/j.issn.1000-9604.2023.05.01
Yong Yang, Zhaoya Gao, Jin Gu
{"title":"Comments on <i>National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)</i>.","authors":"Yong Yang, Zhaoya Gao, Jin Gu","doi":"10.21147/j.issn.1000-9604.2023.05.01","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2023.05.01","url":null,"abstract":"","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"35 5","pages":"431-432"},"PeriodicalIF":0.0,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信